Proton Therapy Cost in China 2026

Proton therapy in China costs $45,000 to $55,000 for a full treatment course. The same treatment runs $100,000 to $200,000 in the United States. That gap — a 60-70% saving — is why increasing numbers of international patients are looking east. This guide covers 2026 prices at every major Chinese proton center, SPHIC's published survival data, which cancers proton therapy works best for, and exactly how foreign patients access treatment in China.

Proton Therapy Cost: China vs. the United States

The price difference is stark. According to Healtra's verified facility data and a 2022 PubMed study analyzing US proton therapy list prices, a full proton therapy course in China averages $45,000-$55,000. In the United States, the same course costs $100,000-$200,000 — with significant variation even between US centers themselves (a 5-10x spread documented in the literature).

In the US, insurance adds another layer of uncertainty. Many insurers approve proton therapy only for pediatric cancers and select head/neck tumors. They routinely deny coverage for prostate cancer despite published clinical evidence. Cash-pay American patients face the full bill — often over $150,000. In China, international patients pay out-of-pocket at the rates above, which typically include treatment planning, all sessions, and basic follow-up.

SPHIC: China's Flagship Proton and Heavy Ion Center

The Shanghai Proton and Heavy Ion Center (SPHIC) opened in May 2015 and has become one of the most published particle therapy centers in the world. It treats patients with both proton therapy and carbon ion (heavy ion) therapy — a technology only a handful of countries offer. SPHIC uses the Siemens active beam scanning system, and its outcomes are published in peer-reviewed journals you can verify yourself on PubMed.

Patient Volume and Track Record

By 2018, SPHIC had treated 1,263 patients: 654 head and neck cases, 205 thoracic cases, and 404 abdominal/pelvic cases. The center reached its 500th patient within just 19 months of opening — a pace that reflected both China's enormous patient population and growing international trust.

SPHIC Published Survival Data

These are not marketing claims. Every figure above comes from peer-reviewed publications indexed in PubMed. SPHIC has treated over 70 international patients from countries including the United States and United Kingdom.

Other Proton and Heavy Ion Centers in China

SPHIC gets the most attention, but China's particle therapy infrastructure extends well beyond Shanghai. A 2022 review in Frontiers in Oncology noted that by the end of 2020, nearly 8,000 patients had already been treated across China's five then-operational centers. By the end of this decade, China expects to operate approximately 20 particle therapy facilities.

Which Cancers Benefit Most from Proton Therapy?

Proton therapy is not for every cancer. Its clinical advantage over conventional X-ray radiation is precision: protons deposit their energy at a specific, controllable depth (the Bragg peak) and stop, rather than passing through tissue and depositing dose beyond the target. This matters most when the tumor is close to critical, radiation-sensitive structures.

Pediatric Cancers

This is where proton therapy's case is strongest. Children's tissues are still developing, making them far more sensitive to radiation damage than adult tissues. Proton therapy reduces the risk of long-term side effects that are well-documented in pediatric X-ray radiation patients: growth disorders, neurocognitive problems, hearing loss, and secondary cancers that can emerge decades later. Mayo Clinic and a 2024 review in JCO Oncology Practice both identify pediatric cancers as the clearest evidence-based indication for proton therapy.

Head and Neck Cancers

The skull base, throat, and neck contain a dense cluster of critical nerves and organs — vision, smell, taste, swallowing function, hearing. X-ray radiation necessarily passes through these structures on its way to the tumor. Proton therapy's precision means doctors can deliver full tumoricidal doses while sparing these surrounding tissues. This is particularly useful for re-irradiation of recurrent tumors, where prior radiation has already stressed nearby organs and further X-ray dose would cause severe damage.

Chordoma and Chondrosarcoma

These are rare, radiation-resistant tumors that occur at the skull base and spine. They require high radiation doses to control — doses that would damage the spinal cord or brainstem if delivered with conventional X-rays. Proton therapy allows safe dose escalation to these tumors. SPHIC's published data shows 85.2% local control at 2 years for these tumors — among the best published results in the world for this indication.

Liver Cancer

Proton therapy offers favorable local tumor control for hepatocellular carcinoma, particularly when the tumor is positioned near critical liver structures where sparing surrounding tissue matters significantly. Clinical data from major centers supports this application.

Prostate Cancer

Proton therapy for prostate cancer is controversial — primarily because US insurers frequently deny coverage despite clinical evidence. SPHIC's published data shows 100% 3-year overall survival and 93% biochemical control — results that rival any treatment modality. For patients paying out-of-pocket, proton therapy in China at $38,000-$52,000 versus $80,000-$150,000 in the US represents a compelling economic case alongside the clinical one.

Treatment Timeline: How Long Will You Be in China?

A typical proton therapy course runs 4 to 8 weeks, with daily sessions Monday through Friday. Most patients receive 20-35 fractions depending on cancer type and treatment protocol. A prostate cancer course, for example, is commonly 28-39 sessions over 7-8 weeks.

International patients should plan for:

• Initial consultation and planning: 3-5 days (CT/MRI simulation, treatment planning)
• Daily treatment: 4-8 weeks depending on protocol
• Post-treatment follow-up: 1-2 days
• Total stay estimate: 5-10 weeks

Heavy Ion Therapy: China's Unique Advantage

Beyond proton therapy, China operates three heavy ion (carbon ion) therapy centers — a technology only Germany, Japan, Italy, Austria, and China offer. Heavy ion therapy uses carbon ions rather than protons, offering different physical and biological properties that may offer advantages for certain radio-resistant tumors.

Gansu Wuwei Tumor Hospital, with its two operational carbon ion systems, has treated 1,820 patients across 40+ conditions. Lanzhou Heavy Ion Hospital, China's newest facility, opened in November 2024. These facilities give China a capability that US patients cannot access domestically — and one reason why medical tourism for particle therapy to China is a growing trend even among Western patients.

How International Patients Access Proton Therapy in China

Several pathways exist for international patients seeking proton therapy in China:

1. Direct contact with the hospital's international department: SPHIC and other major centers have English-speaking international patient coordinators. Most will review medical records via email before arrival.
2. Medical tourism facilitators: Companies specializing in China's advanced medical facilities can coordinate appointments, translation, visa letters, and accommodation. Costs for the facilitator service typically range $2,000-$5,000 on top of treatment costs.
3. Insurance and embassy channels: Some international health insurers have negotiated partnerships with Chinese proton centers. Check with your insurer. Several embassies in Beijing maintain lists of accredited international hospitals.

Frequently Asked Questions

How much does proton therapy cost in China vs the US?

Proton therapy in China costs $45,000-$55,000 for a full treatment course, compared to $100,000-$200,000 in the United States. That is a 60-70% savings. Per-session costs run $1,500-$2,500 in China versus $4,700-$6,700 per session in the US.

How many proton therapy centers does China have?

China operates 11-14 proton therapy centers as of 2026, with an additional 12 under construction and 4 in the planning phase. The country also has 3 heavy ion (carbon ion) therapy centers — a technology only a handful of nations offer.

What are SPHIC's published survival rates?

SPHIC (Shanghai Proton and Heavy Ion Center) has published peer-reviewed outcomes: 100% 3-year overall survival for prostate cancer (154 patients), 94.3% for major salivary gland tumors, 100% 2-year survival for chordoma/chondrosarcoma, and a 69.5% overall 5-year survival rate across its entire patient population.

How long does proton therapy treatment take?

A typical proton therapy course runs 4-8 weeks, with daily sessions Monday through Friday. Most patients receive 20-35 sessions (fractions) depending on cancer type. For common cancers like prostate cancer, a standard course is approximately 28-39 sessions over 7-8 weeks.

Does insurance cover proton therapy?

In the US, insurance coverage is inconsistent — many insurers only approve proton therapy for pediatric cancers and certain head/neck tumors, and deny coverage for more common cancers like prostate despite clinical evidence. Cash-pay patients face the full $100,000-$200,000 bill. In China, international patients pay out-of-pocket at significantly lower rates.

Which cancers benefit most from proton therapy?

Proton therapy shows strongest evidence for: pediatric cancers (reduces long-term side effects in developing tissues), head and neck cancers (preserves vision, smell, taste, swallowing), chordoma and chondrosarcoma at the skull base and spine (allows safe dose escalation near the spinal cord), liver cancer, and prostate cancer.

Making the Decision

Proton therapy is not the right choice for every cancer patient. For some indications — pediatric cancers, skull base tumors, head and neck recurrences — the clinical case for proton over X-ray radiation is well-established and widely accepted. For others — prostate cancer especially — the clinical benefits are real but contested by insurers who focus on cost-containment over individual patient outcomes.

If you are an international patient considering proton therapy, the economics are straightforward: China's top proton centers offer treatment outcomes that meet or exceed global benchmarks, at 40-60% lower cost than US centers. SPHIC's published data, verified through PubMed, makes the outcomes case on its own.

The practical path forward starts with getting your records reviewed. Most Chinese proton centers will provide an initial opinion based on your medical history and imaging at no charge. That first step costs nothing and takes a few days — and it may open a door to treatment options that, back home, carry a price tag you cannot afford.